{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:20:49Z","timestamp":1791872449032,"version":"4.3.4"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Brock University unrestricted funds (startup) Brock-Niagara Validation Prototyping and Manufacturing Applied Project Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-53886-y","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T10:30:59Z","timestamp":1732530659000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["GSK3 inhibition improves skeletal muscle function and whole-body metabolism in male mouse models of Duchenne muscular dystrophy"],"prefix":"10.1038","volume":"15","author":[{"given":"Bianca M.","family":"Marcella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briana L.","family":"Hockey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9196-0757","authenticated-orcid":false,"given":"Jessica L.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennedy C.","family":"Whitley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia S.","family":"Geromella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan W.","family":"Baranowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colton J. F.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Silvera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8418-449X","authenticated-orcid":false,"given":"Sophie I.","family":"Hamstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc J.","family":"Wasilewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W. E.","family":"Crozier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie A. T.","family":"Marais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5052-5927","authenticated-orcid":false,"given":"Gabsang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Vandenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4638-5586","authenticated-orcid":false,"given":"Brian D.","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4749-8120","authenticated-orcid":false,"given":"Adam J.","family":"MacNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1577-2658","authenticated-orcid":false,"given":"Rebecca E. K.","family":"MacPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4500-3347","authenticated-orcid":false,"given":"Val A.","family":"Fajardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,25]]},"reference":[{"key":"53886_CR1","doi-asserted-by":"publisher","first-page":"18168","DOI":"10.3390\/molecules201018168","volume":"20","author":"MS Falzarano","year":"2015","unstructured":"Falzarano, M. S., Scotton, C., Passarelli, C. & Ferlini, A. Duchenne muscular dystrophy: from diagnosis to therapy. Molecules 20, 18168\u201318184 (2015).","journal-title":"Molecules"},{"key":"53886_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/ajmg.c.32000","volume":"190","author":"D Gruber","year":"2022","unstructured":"Gruber, D. et al. Newborn screening for Duchenne muscular dystrophy-early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy. Am. J. Med. Genet. C Semin. Med. Genet. 190, 197\u2013205 (2022).","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"53886_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan, D., Goemans, N., Takeda, S. I., Mercuri, E. & Aartsma-Rus, A. Duchenne muscular dystrophy. Nat. Rev. Dis. Prim. 7, 13 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"53886_CR4","doi-asserted-by":"publisher","first-page":"e133276","DOI":"10.1172\/jci.insight.133276","volume":"5","author":"DW Hammers","year":"2020","unstructured":"Hammers, D. W. et al. Glucocorticoids counteract hypertrophic effects of myostatin inhibition in dystrophic muscle. JCI Insight 5, e133276 (2020).","journal-title":"JCI Insight"},{"key":"53886_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0140-6736(17)32160-8","volume":"391","author":"CM McDonald","year":"2018","unstructured":"McDonald, C. M. et al. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study. Lancet 391, 451\u2013461 (2018).","journal-title":"Lancet"},{"key":"53886_CR6","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3892\/etm.2021.9875","volume":"21","author":"T Zhang","year":"2021","unstructured":"Zhang, T. & Kong, X. Recent advances of glucocorticoids in the treatment of Duchenne muscular dystrophy (Review). Exp. Ther. Med. 21, 447 (2021).","journal-title":"Exp. Ther. Med."},{"key":"53886_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant, D. J. et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 17, 347\u2013361 (2018).","journal-title":"Lancet Neurol."},{"key":"53886_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00198-022-06578-6","volume":"34","author":"K Phung","year":"2023","unstructured":"Phung, K. et al. Risk factors associated with prevalent vertebral fractures in Duchenne muscular dystrophy. Osteoporos. Int. 34, 147\u2013160 (2023).","journal-title":"Osteoporos. Int."},{"key":"53886_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","volume":"148","author":"E Beurel","year":"2015","unstructured":"Beurel, E., Grieco, S. F. & Jope, R. S. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharm. Ther. 148, 114\u2013131 (2015).","journal-title":"Pharm. Ther."},{"key":"53886_CR10","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cyto.2010.10.009","volume":"53","author":"H Wang","year":"2011","unstructured":"Wang, H., Brown, J. & Martin, M. Glycogen synthase kinase 3: a point of convergence for the host inflammatory response. Cytokine 53, 130\u2013140 (2011).","journal-title":"Cytokine"},{"key":"53886_CR11","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1210\/en.2013-1155","volume":"154","author":"J Gillespie","year":"2013","unstructured":"Gillespie, J. et al. GSK-3\u03b2 function in bone regulates skeletal development, whole-body metabolism, and male life span. Endocrinology 154, 3702\u20133718 (2013).","journal-title":"Endocrinology"},{"key":"53886_CR12","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.bbadis.2014.12.006","volume":"1852","author":"NA Pansters","year":"2015","unstructured":"Pansters, N. A. et al. Muscle-specific GSK-3beta ablation accelerates regeneration of disuse-atrophied skeletal muscle. Biochim. Biophys. Acta 1852, 490\u2013506 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"53886_CR13","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14517","volume":"8","author":"KC Whitley","year":"2020","unstructured":"Whitley, K. C. et al. GSK3 inhibition with low dose lithium supplementation augments murine muscle fatigue resistance and specific force production. Physiol. Rep. 8, e14517 (2020).","journal-title":"Physiol. Rep."},{"key":"53886_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107047","volume":"26","author":"RW Baranowski","year":"2023","unstructured":"Baranowski, R. W. et al. Toward countering muscle and bone loss with spaceflight: GSK3 as a potential target. iScience 26, 107047 (2023).","journal-title":"iScience"},{"key":"53886_CR15","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3390\/cells8111340","volume":"8","author":"N Kurgan","year":"2019","unstructured":"Kurgan, N. et al. A low-therapeutic dose of lithium inhibits GSK3 and enhances myoblast fusion in C2C12 Cells. Cells 8, 1340 (2019).","journal-title":"Cells"},{"key":"53886_CR16","doi-asserted-by":"publisher","first-page":"5081","DOI":"10.3390\/ijms22105081","volume":"22","author":"TM Mirzoev","year":"2021","unstructured":"Mirzoev, T. M., Sharlo, K. A. & Shenkman, B. S. The role of GSK-3\u03b2 in the regulation of protein turnover, myosin phenotype, and oxidative capacity in skeletal muscle under disuse conditions. Int. J. Mol. Sci. 22, 5081 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"53886_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/hmg\/ddh037","volume":"13","author":"JV Chakkalakal","year":"2004","unstructured":"Chakkalakal, J. V. et al. Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice. Hum. Mol. Genet. 13, 379\u2013388 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"53886_CR18","doi-asserted-by":"publisher","first-page":"7791","DOI":"10.1073\/pnas.0932671100","volume":"100","author":"JV Chakkalakal","year":"2003","unstructured":"Chakkalakal, J. V. et al. Expression of utrophin A mRNA correlates with the oxidative capacity of skeletal muscle fiber types and is regulated by calcineurin\/NFAT signaling. Proc. Natl. Acad. Sci. USA 100, 7791\u20137796 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"53886_CR19","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1042\/BCJ20220153","volume":"479","author":"X Duan","year":"2022","unstructured":"Duan, X. et al. Trafficking regulator of GLUT4-1 (TRARG1) is a GSK3 substrate. Biochem. J. 479, 1237\u20131256 (2022).","journal-title":"Biochem. J."},{"key":"53886_CR20","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.diabres.2007.01.033","volume":"77","author":"J Lee","year":"2007","unstructured":"Lee, J. & Kim, M. S. The role of GSK3 in glucose homeostasis and the development of insulin resistance. Diabetes Res. Clin. Pract. 77, S49\u2013S57 (2007).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"53886_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-019-1210-1","volume":"14","author":"J Bai","year":"2019","unstructured":"Bai, J., Xu, Y., Dieo, Y. & Sun, G. Combined low-dose LiCl and LY294002 for the treatment of osteoporosis in ovariectomized rats. J. Orthop. Surg. Res. 14, 177 (2019).","journal-title":"J. Orthop. Surg. Res."},{"key":"53886_CR22","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/jor.23799","volume":"36","author":"K Vachhani","year":"2018","unstructured":"Vachhani, K., Whyne, C., Wang, Y., Burns, D. M. & Nam, D. Low-dose lithium regimen enhances endochondral fracture healing in osteoporotic rodent bone. J. Orthop. Res. 36, 1783\u20131789 (2018).","journal-title":"J. Orthop. Res."},{"key":"53886_CR23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.bone.2011.11.007","volume":"50","author":"R Marsell","year":"2012","unstructured":"Marsell, R. et al. GSK-3 inhibition by an orally active small molecule increases bone mass in rats. Bone 50, 619\u2013627 (2012).","journal-title":"Bone"},{"key":"53886_CR24","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.bbrc.2019.02.066","volume":"511","author":"N Kurgan","year":"2019","unstructured":"Kurgan, N. et al. Low dose lithium supplementation activates Wnt\/beta-catenin signalling and increases bone OPG\/RANKL ratio in mice. Biochem. Biophys. Res. Commun. 511, 394\u2013397 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"53886_CR25","first-page":"Cd003725","volume":"2016","author":"E Matthews","year":"2016","unstructured":"Matthews, E., Brassington, R., Kuntzer, T., Jichi, F. & Manzur, A. Y. Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database Syst. Rev. 2016, Cd003725 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"key":"53886_CR26","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant, D. J. et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 17, 251\u2013267 (2018).","journal-title":"Lancet Neurol."},{"key":"53886_CR27","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1542\/peds.2018-0333F","volume":"142","author":"DR Weber","year":"2018","unstructured":"Weber, D. R., Hadjiyannakis, S., McMillan, H. J., Noritz, G. & Ward, L. M. Obesity and endocrine management of the patient with duchenne muscular dystrophy. Pediatrics 142, S43\u2013s52 (2018).","journal-title":"Pediatrics"},{"key":"53886_CR28","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1172\/JCI64081","volume":"122","author":"K Jones","year":"2012","unstructured":"Jones, K. et al. GSK3beta mediates muscle pathology in myotonic dystrophy. J. Clin. Investig. 122, 4461\u20134472 (2012).","journal-title":"J. Clin. Investig."},{"key":"53886_CR29","doi-asserted-by":"publisher","first-page":"10650","DOI":"10.3390\/ijms241310650","volume":"24","author":"M Lutz","year":"2023","unstructured":"Lutz, M. et al. Therapeutic targeting of the GSK3\u03b2-CUGBP1 pathway in myotonic dystrophy. Int. J. Mol. Sci. 24, 10650 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"53886_CR30","doi-asserted-by":"publisher","first-page":"e26555","DOI":"10.4161\/rdis.26555","volume":"1","author":"C Wei","year":"2013","unstructured":"Wei, C., Jones, K., Timchenko, N. A. & Timchenko, L. GSK3\u03b2 is a new therapeutic target for myotonic dystrophy type 1. Rare Dis. 1, e26555 (2013).","journal-title":"Rare Dis."},{"key":"53886_CR31","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1096\/fj.201700700R","volume":"32","author":"C Wei","year":"2018","unstructured":"Wei, C. et al. Correction of GSK3beta at young age prevents muscle pathology in mice with myotonic dystrophy type 1. FASEB J. 32, 2073\u20132085 (2018).","journal-title":"FASEB J."},{"key":"53886_CR32","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000318","volume":"5","author":"AR Findlay","year":"2019","unstructured":"Findlay, A. R. et al. Lithium chloride corrects weakness and myopathology in a preclinical model of LGMD1D. Neurol. Genet. 5, e318 (2019).","journal-title":"Neurol. Genet."},{"key":"53886_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/1357-2725(95)00119-0","volume":"28","author":"E Villa-Moruzzi","year":"1996","unstructured":"Villa-Moruzzi, E., Puntoni, F. & Marin, O. Activation of protein phosphatase-1 isoforms and glycogen synthase kinase-3 beta in muscle from mdx mice. Int. J. Biochem. Cell Biol. 28, 13\u201322 (1996).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"53886_CR34","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ejmech.2016.09.058","volume":"125","author":"I Khan","year":"2017","unstructured":"Khan, I., Tantray, M. A., Alam, M. S. & Hamid, H. Natural and synthetic bioactive inhibitors of glycogen synthase kinase. Eur. J. Med. Chem. 125, 464\u2013477 (2017).","journal-title":"Eur. J. Med. Chem."},{"key":"53886_CR35","doi-asserted-by":"publisher","first-page":"C1289","DOI":"10.1152\/ajpcell.00061.2019","volume":"317","author":"MS Noori","year":"2019","unstructured":"Noori, M. S. et al. Identification of a novel selective and potent inhibitor of glycogen synthase kinase-3. Am. J. Physiol. Cell Physiol. 317, C1289\u2013c1303 (2019).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"53886_CR36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pediatrneurol.2020.08.001","volume":"112","author":"J Horrigan","year":"2020","unstructured":"Horrigan, J. et al. A phase 2 study of AMO-02 (Tideglusib) in congenital and childhood-onset myotonic dystrophy type 1 (DM1). Pediatr. Neurol. 112, 84\u201393 (2020).","journal-title":"Pediatr. Neurol."},{"key":"53886_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-70987-y","volume":"10","author":"DW Hammers","year":"2020","unstructured":"Hammers, D. W. et al. The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy. Sci. Rep. 10, 14070 (2020).","journal-title":"Sci. Rep."},{"key":"53886_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75020-w","volume":"10","author":"M Balasubramaniam","year":"2020","unstructured":"Balasubramaniam, M. et al. Structural modeling of GSK3\u03b2 implicates the inactive (DFG-out) conformation as the target bound by TDZD analogs. Sci. Rep. 10, 18326 (2020).","journal-title":"Sci. Rep."},{"key":"53886_CR39","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1172\/JCI64081","volume":"122","author":"K Jones","year":"2012","unstructured":"Jones, K. et al. GSK3\u03b2 mediates muscle pathology in myotonic dystrophy. J. Clin. Investig. 122, 4461\u20134472 (2012).","journal-title":"J. Clin. Investig."},{"key":"53886_CR40","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/hmg\/ddv460","volume":"25","author":"WD Coley","year":"2016","unstructured":"Coley, W. D. et al. Effect of genetic background on the dystrophic phenotype in mdx mice. Hum. Mol. Genet. 25, 130\u2013145 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"53886_CR41","unstructured":"Hoffman, E. & Winder, S. J. A Modified wire hanging apparatus for small animal muscle function testing. PLoS Curr. 8 ecurrents.md.1e2bec4e78697b7b0ff80ea25a1d38be (2016)."},{"key":"53886_CR42","doi-asserted-by":"publisher","first-page":"8110","DOI":"10.1096\/fj.201802488R","volume":"33","author":"M van Putten","year":"2019","unstructured":"van Putten, M. et al. Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy. FASEB J. 33, 8110\u20138124 (2019).","journal-title":"FASEB J."},{"key":"53886_CR43","doi-asserted-by":"publisher","first-page":"1224.1226","DOI":"10.1096\/fasebj.30.1_supplement.1224.6","volume":"30","author":"VA Fajardo","year":"2016","unstructured":"Fajardo, V. A. et al. Sarcolipin deletion in mdx mice worsens dystrophic pathology by impairing calcineurin signaling and reducing utrophin expression. FASEB J. 30, 1224.1226 (2016).","journal-title":"FASEB J."},{"key":"53886_CR44","doi-asserted-by":"publisher","first-page":"R983","DOI":"10.1152\/ajpregu.00375.2007","volume":"294","author":"N Stupka","year":"2008","unstructured":"Stupka, N., Schertzer, J. D., Bassel-Duby, R., Olson, E. N. & Lynch, G. S. Stimulation of calcineurin Aalpha activity attenuates muscle pathophysiology in mdx dystrophic mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R983\u2013R992 (2008).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"53886_CR45","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/ncb1101-1009","volume":"3","author":"C Rommel","year":"2001","unstructured":"Rommel, C. et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K\/Akt\/mTOR and PI(3)K\/Akt\/GSK3 pathways. Nat. Cell Biol. 3, 1009\u20131013 (2001).","journal-title":"Nat. Cell Biol."},{"key":"53886_CR46","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1113\/jphysiol.2006.120048","volume":"579","author":"T Shen","year":"2007","unstructured":"Shen, T., Cseresnyes, Z., Liu, Y., Randall, W. R. & Schneider, M. F. Regulation of the nuclear export of the transcription factor NFATc1 by protein kinases after slow fibre type electrical stimulation of adult mouse skeletal muscle fibres. J. Physiol. 579, 535\u2013551 (2007).","journal-title":"J. Physiol."},{"key":"53886_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104972","volume":"25","author":"REG Cleverdon","year":"2022","unstructured":"Cleverdon, R. E. G. et al. Sarco(endo)plasmic reticulum Ca(2+)-ATPase function is impaired in skeletal and cardiac muscles from young DBA\/2J mdx mice. iScience 25, 104972 (2022).","journal-title":"iScience"},{"key":"53886_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31753-3","volume":"8","author":"J Strakova","year":"2018","unstructured":"Strakova, J. et al. Integrative effects of dystrophin loss on metabolic function of the mdx mouse. Sci. Rep. 8, 13624 (2018).","journal-title":"Sci. Rep."},{"key":"53886_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07868-z","volume":"12","author":"P Podkalicka","year":"2022","unstructured":"Podkalicka, P. et al. miR-378 affects metabolic disturbances in the mdx model of Duchenne muscular dystrophy. Sci. Rep. 12, 3945 (2022).","journal-title":"Sci. Rep."},{"key":"53886_CR50","doi-asserted-by":"publisher","first-page":"S157","DOI":"10.2337\/dc09-S302","volume":"32","author":"RA DeFronzo","year":"2009","unstructured":"DeFronzo, R. A. & Tripathy, D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 32, S157\u2013S163 (2009).","journal-title":"Diabetes Care"},{"key":"53886_CR51","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/978-1-0716-2772-3_24","volume":"2587","author":"M Wintzinger","year":"2023","unstructured":"Wintzinger, M. et al. Effects of glucocorticoids in murine models of Duchenne and limb-girdle muscular dystrophy. Methods Mol. Biol. 2587, 467\u2013478 (2023).","journal-title":"Methods Mol. Biol."},{"key":"53886_CR52","doi-asserted-by":"publisher","first-page":"e132402","DOI":"10.1172\/jci.insight.132402","volume":"4","author":"M Quattrocelli","year":"2019","unstructured":"Quattrocelli, M. et al. Pulsed glucocorticoids enhance dystrophic muscle performance through epigenetic-metabolic reprogramming. JCI Insight 4, e132402 (2019).","journal-title":"JCI Insight"},{"key":"53886_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102568","volume":"298","author":"MS Geromella","year":"2022","unstructured":"Geromella, M. S. et al. Low-dose lithium supplementation promotes adipose tissue browning and sarco(endo)plasmic reticulum Ca(2+) ATPase uncoupling in muscle. J. Biol. Chem. 298, 102568 (2022).","journal-title":"J. Biol. Chem."},{"key":"53886_CR54","first-page":"jrm00250","volume":"54","author":"S Hammer","year":"2022","unstructured":"Hammer, S. et al. Exercise training in Duchenne muscular dystrophy: a systematic review and meta-analysis. J. Rehabil. Med. 54, jrm00250 (2022).","journal-title":"J. Rehabil. Med."},{"key":"53886_CR55","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/mus.27137","volume":"63","author":"DJ Lott","year":"2021","unstructured":"Lott, D. J. et al. Safety, feasibility, and efficacy of strengthening exercise in Duchenne muscular dystrophy. Muscle Nerve 63, 320\u2013326 (2021).","journal-title":"Muscle Nerve"},{"key":"53886_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42203-z","volume":"9","author":"AS Zelikovich","year":"2019","unstructured":"Zelikovich, A. S., Quattrocelli, M., Salamone, I. M., Kuntz, N. L. & McNally, E. M. Moderate exercise improves function and increases adiponectin in the mdx mouse model of muscular dystrophy. Sci. Rep. 9, 5770 (2019).","journal-title":"Sci. Rep."},{"key":"53886_CR57","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s42826-019-0035-8","volume":"36","author":"YJ Kim","year":"2020","unstructured":"Kim, Y. J., Kim, H. J., Lee, W. J. & Seong, J. K. A comparison of the metabolic effects of treadmill and wheel running exercise in mouse model. Lab. Anim. Res. 36, 3 (2020).","journal-title":"Lab. Anim. Res."},{"key":"53886_CR58","doi-asserted-by":"crossref","unstructured":"Hamstra, S. I., et al. Beyond its psychiatric use: the benefits of low dose lithium supplementation. Curr. Neuropharmacol. 21, 891\u2013910 (2022).","DOI":"10.2174\/1570159X20666220302151224"},{"key":"53886_CR59","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0165-6147(03)00206-2","volume":"24","author":"RS Jope","year":"2003","unstructured":"Jope, R. S. Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharm. Sci. 24, 441\u2013443 (2003).","journal-title":"Trends Pharm. Sci."},{"key":"53886_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/srep40716","volume":"7","author":"J Huang","year":"2017","unstructured":"Huang, J., Guo, X., Li, W. & Zhang, H. Activation of Wnt\/\u03b2-catenin signalling via GSK3 inhibitors direct differentiation of human adipose stem cells into functional hepatocytes. Sci. Rep. 7, 40716 (2017).","journal-title":"Sci. Rep."},{"key":"53886_CR61","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1007\/s11033-010-0328-3","volume":"38","author":"Y Yang","year":"2011","unstructured":"Yang, Y. et al. Accumulation of \u03b2-catenin by lithium chloride in porcine myoblast cultures accelerates cell differentiation. Mol. Biol. Rep. 38, 2043\u20132049 (2011).","journal-title":"Mol. Biol. Rep."},{"key":"53886_CR62","first-page":"3733","volume":"220","author":"J Tallis","year":"2017","unstructured":"Tallis, J. et al. The effects of 8 weeks voluntary wheel running on the contractile performance of isolated locomotory (soleus) and respiratory (diaphragm) skeletal muscle during early ageing. J. Exp. Biol. 220, 3733\u20133741 (2017).","journal-title":"J. Exp. Biol."},{"key":"53886_CR63","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1016\/j.ajpath.2018.07.015","volume":"188","author":"C Delacroix","year":"2018","unstructured":"Delacroix, C. et al. Improvement of dystrophic muscle fragility by short-term voluntary exercise through activation of calcineurin pathway in mdx mice. Am. J. Pathol. 188, 2662\u20132673 (2018).","journal-title":"Am. J. Pathol."},{"key":"53886_CR64","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1096\/fj.201700700R","volume":"32","author":"C Wei","year":"2018","unstructured":"Wei, C. et al. Correction of GSK3\u03b2 at young age prevents muscle pathology in mice with myotonic dystrophy type 1. FASEB J. 32, 2073\u20132085 (2018).","journal-title":"FASEB J."},{"key":"53886_CR65","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0026-0495(94)90255-0","volume":"43","author":"H Rico","year":"1994","unstructured":"Rico, H., Revilla, M., Villa, L. F., Alvarez del Buergo, M. & Ruiz-Contreras, D. Determinants of total-body and regional bone mineral content and density in postpubertal normal women. Metabolism 43, 263\u2013266 (1994).","journal-title":"Metabolism"},{"key":"53886_CR66","doi-asserted-by":"publisher","first-page":"205963","DOI":"10.1155\/2013\/205963","volume":"2013","author":"MR Salamat","year":"2013","unstructured":"Salamat, M. R., Salamat, A. H., Abedi, I. & Janghorbani, M. Relationship between weight, body mass index, and bone mineral density in men referred for dual-energy X-ray absorptiometry scan in Isfahan, Iran. J. Osteoporos. 2013, 205963 (2013).","journal-title":"J. Osteoporos."},{"key":"53886_CR67","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1097\/CM9.0000000000000143","volume":"132","author":"T-T Liu","year":"2019","unstructured":"Liu, T.-T., Li, X.-D., Wang, W.-Z., Zhang, J.-G. & Yang, D.-Z. Efficacy of weight adjusted bone mineral content in osteoporosis diagnosis in Chinese female population. Chin. Med. J. 132, 772\u2013781 (2019).","journal-title":"Chin. Med. J."},{"key":"53886_CR68","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3389\/fphar.2020.00430","volume":"11","author":"SK Wong","year":"2020","unstructured":"Wong, S. K., Chin, K. Y. & Ima-Nirwana, S. The skeletal-protecting action and mechanisms of action for mood-stabilizing drug lithium chloride: current evidence and future potential research areas. Front. Pharm. 11, 430 (2020).","journal-title":"Front. Pharm."},{"key":"53886_CR69","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1016\/j.celrep.2016.05.016","volume":"15","author":"IY Choi","year":"2016","unstructured":"Choi, I. Y. et al. Concordant but varied phenotypes among duchenne muscular dystrophy patient-specific myoblasts derived using a human iPSC-based model. Cell Rep. 15, 2301\u20132312 (2016).","journal-title":"Cell Rep."},{"key":"53886_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/1750-2187-6-12","volume":"6","author":"S Tanaka","year":"2011","unstructured":"Tanaka, S., Terada, K. & Nohno, T. Canonical Wnt signaling is involved in switching from cell proliferation to myogenic differentiation of mouse myoblast cells. J. Mol. Signal 6, 12 (2011).","journal-title":"J. Mol. Signal"},{"key":"53886_CR71","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00018-010-0467-7","volume":"68","author":"NA Pansters","year":"2011","unstructured":"Pansters, N. A. et al. Segregation of myoblast fusion and muscle-specific gene expression by distinct ligand-dependent inactivation of GSK-3beta. Cell Mol. Life Sci. 68, 523\u2013535 (2011).","journal-title":"Cell Mol. Life Sci."},{"key":"53886_CR72","doi-asserted-by":"publisher","first-page":"C453","DOI":"10.1152\/ajpcell.00068.2005","volume":"290","author":"JL van der Velden","year":"2006","unstructured":"van der Velden, J. L. et al. Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation. Am. J. Physiol. Cell Physiol. 290, C453\u2013C462 (2006).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"53886_CR73","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1074\/jbc.M707812200","volume":"283","author":"JL van der Velden","year":"2008","unstructured":"van der Velden, J. L., Schols, A. M., Willems, J., Kelders, M. C. & Langen, R. C. Glycogen synthase kinase 3 suppresses myogenic differentiation through negative regulation of NFATc3. J. Biol. Chem. 283, 358\u2013366 (2008).","journal-title":"J. Biol. Chem."},{"key":"53886_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116056","volume":"170","author":"L Matias-Valiente","year":"2024","unstructured":"Matias-Valiente, L. et al. Evaluation of pro-regenerative and anti-inflammatory effects of isolecanoric acid in the muscle: potential treatment of Duchenne Muscular Dystrophy. Biomed. Pharmacother. 170, 116056 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"53886_CR75","first-page":"184","volume":"9","author":"J Mendez","year":"1960","unstructured":"Mendez, J. & Keys, A. Density and composition of mammalian muscle. Metabolism 9, 184\u2013188 (1960).","journal-title":"Metabolism"},{"key":"53886_CR76","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1113\/jphysiol.1988.sp017279","volume":"404","author":"SV Brooks","year":"1988","unstructured":"Brooks, S. V. & Faulkner, J. A. Contractile properties of skeletal muscles from young, adult and aged mice. J. Physiol. 404, 71\u201382 (1988).","journal-title":"J. Physiol."},{"key":"53886_CR77","doi-asserted-by":"publisher","first-page":"e35273","DOI":"10.1371\/journal.pone.0035273","volume":"7","author":"D Bloemberg","year":"2012","unstructured":"Bloemberg, D. & Quadrilatero, J. Rapid determination of myosin heavy chain expression in rat, mouse, and human skeletal muscle using multicolor immunofluorescence analysis. PLoS One 7, e35273 (2012).","journal-title":"PLoS One"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53886-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53886-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53886-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T12:03:21Z","timestamp":1732536201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53886-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,25]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["53886"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-53886-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,25]]},"assertion":[{"value":"22 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests. A portion of this project, specifically the aged (28\u201330 weeks) tideglusib experiments, was funded by AMO-Pharma in partnership with a Brock-Niagara Validation Prototyping and Manufacturing Applied Project Grant (1:2 monetary ratio). AMO-Pharma also provided the tideglusib for the aged tideglusib experiments. For all other experiments, tideglusib was purchased from Sigma Alrdich (SML0339).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10210"}}